尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Ben-Maimon Carole. Director active across 1 company, notably Larimar Therapeutics, Inc.. Cumulatively, 6 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €117k. Activity tracked since 16 September 2022. The latest transaction was disclosed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
BEN-MAIMON CAROLE is a declarant linked to Larimar Therapeutics, Inc. in the filings provided. She has 6 filings in total, and across the 6 sampled filings from 2022-09-19 to 2026-01-27, buys total 117209 EUR and sells total 0 EUR, with the modal transaction nature listed as Attribution.